申请人:Eickmeier Christian
公开号:US20090325940A1
公开(公告)日:2009-12-31
The present invention relates to substituted 1,2-ethylenediamines of general formula (I)
wherein the groups R
1
to R
15
, A, B, L, i as well as X
1
-X
4
are defined as in the specification and claims and the use thereof for the treatment of Alzheimer's disease (AD) and similar diseases.